Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 Subgroup analyses of rates of target vessel revascularization (TVR) and 1-year medical care cost differences between the paclitaxel and control stent groups along with the associated cost-effectiveness ratios for paclitaxel-eluting stent (PES) versus bare-metal stent implantation. Dominant indicates those subgroups for which PES implantation was economically dominant (i.e., lower overall costs and better clinical outcomes). LAD = left anterior descending coronary artery.
|
